PMGC Holdings ELAB
NASDAQ ELAB
$3.54 -0.09 (-2.48%)
At close: Sep 30, 2026 · 4:00 PM EDT

PMGC Holdings (ELAB) Capital Expenditures (2022 - 2026)

Updated

PMGC Holdings' Capital Expenditures was -$27,569 in Q2 2026.

Analysis

PMGC Holdings (ELAB) Capital Expenditures (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, PMGC Holdings' Capital Expenditures was $682,179 through Jun 30, 2026; for FY2025, it came in at $442,255.

  • Capital Expenditures shows a three-year compound annual growth rate of 131.8% (FY2022 to FY2025).
  • In earlier years, Capital Expenditures was $9,160 in FY2024 (-18.1%), $11,191 in FY2023 (-68.5%) and $35,527 in FY2022.
  • The Q2 2026 figure marks the lowest quarterly Capital Expenditures since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 PMGC Holdings 1.73 Mn -46.63 Mn 385,691.00 -27,569.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -27,569.00
Mar 31, 2026 363,087.00
Dec 31, 2025 346,661.00
Mar 31, 2024 9,160.00
Mar 31, 2023 11,191.00
Dec 31, 2022 -36.89 Mn
API Access

PMGC Holdings Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ELAB&period=max&api_key=YOUR_API_KEY